Report on the Audit Committee's Supervision of the Accounting Firm's Responsibilities
According to the Company Law, Securities Law, Guidelines for the Governance of Listed Companies, Management Measures for the Appointment of Accounting Firms by State-owned Enterprises and Listed Companies, and the Shenzhen Stock Exchange's Self-Regulatory Guidelines No. 2 for the Standard Operation of GEM Listed Companies, as well as the Articles of Association and the Audit Committee Work Rules of Hubei Hendi Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company"), the Audit Committee of the Board of Directors has diligently fulfilled its responsibilities. The following is the report on the Audit Committee's evaluation of the accounting firm's performance and supervision for the 2025 fiscal year:
I. Basic Information of the Audit Firm for the 2025 Annual Audit
(1) Basic Information of the Audit Firm
Da Xin Accounting Firm (Special General Partnership) (hereinafter referred to as "Da Xin") was established in 1985 and transformed into a special general partnership in March 2012. Its headquarters is located in Beijing, with the registered address at Room 2206, 22nd Floor, No. 1 Zhichun Road, Haidian District, Beijing. The chief partner is Mr. Xie Zemin. As of December 31, 2025, Da Xin has a total of 3,914 employees, including 182 partners and 1,053 certified public accountants. Among the certified public accountants, over 500 have signed audit reports for securities services.
(2) Procedures for Appointing the Audit Firm
The 12th meeting of the second Board of Directors and the 2024 Annual General Meeting approved the proposal to reappoint Da Xin as the Company's audit institution for the 2025 fiscal year.